Insulin lispro Subcutaneous and Laronidase Intravenous
Determining the interaction of Insulin lispro Subcutaneous and Laronidase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: laronidase
Brand name: Aldurazyme
Synonyms: Laronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Larotrectinib
- Insulin lispro Subcutaneous-Larotrectinib Capsules
- Insulin lispro Subcutaneous-Larotrectinib Oral Solution
- Insulin lispro Subcutaneous-Larotrectinib Sulfate
- Insulin lispro Subcutaneous-Lartruvo
- Insulin lispro Subcutaneous-Larynex
- Laronidase Intravenous-Insulin NPH
- Laronidase Intravenous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Laronidase Intravenous-Insulin NPH (Vials)
- Laronidase Intravenous-Insulin NPH and Insulin Regular
- Laronidase Intravenous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Laronidase Intravenous-Insulin NPH and Insulin Regular (Vials)